Can blue light therapy treat neonatal jaundice?
Generally, blue light therapy can treat neonatal jaundice, but relying solely on blue light therapy may have limited effectiveness. The specific analysis is as follows:
Neonatal jaundice is a common condition during the neonatal period, typically appearing two to four days after birth. Its main characteristic is a yellow appearance of the skin and sclera. Blue light therapy works by exposing the newborn's skin to blue light of a specific wavelength, converting unconjugated bilirubin into water-soluble isomers that are more easily excreted through bile and urine, thereby accelerating bilirubin metabolism and elimination. This effectively reduces the bilirubin levels in the newborn's blood and alleviates jaundice symptoms.
However, if a newborn has severe hyperbilirubinemia, blue light therapy alone may not sufficiently and rapidly lower bilirubin levels. Under a doctor's guidance, more aggressive interventions, such as exchange transfusion therapy, may be necessary.
During treatment, maintaining good care practices, such as regular monitoring of bilirubin levels and ensuring adequate feeding, can help the newborn recover health more quickly.